Yahoo
OTC Markets OTCID USD

AVVAA World Health Care Products, Inc. (AVVH)

0.0029 +0.0002 (+7.41%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for AVVH
  • Previous Close 0.0027
  • Open 0.0027
  • Bid 0.0026 x 65881900
  • Ask 0.0029 x 1000000
  • Day's Range 0.0027 - 0.0029
  • 52 Week Range 0.0008 - 0.0048
  • Volume 35,385
  • Avg. Volume 330,068
  • Market Cap (intraday) 2.804M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) -29.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.

avvaaworldhealth.com

5

Full Time Employees

May 31

Fiscal Year Ends

Mortgage Finance

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AVVH
35.56%
S&P 500 (^GSPC)
7.76%

1-Year Return

AVVH
30.79%
S&P 500 (^GSPC)
9.77%

3-Year Return

AVVH
17.14%
S&P 500 (^GSPC)
68.96%

5-Year Return

AVVH
93.22%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    45,873.67%

  • Return on Assets (ttm)

    -1,593.67%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    37.46k

  • Net Income Avi to Common (ttm)

    17.18M

  • Diluted EPS (ttm)

    -29.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.17k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -22.46M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: